Dr. Wang's main responsibility at the National Human Genome Research Institute (NHGRI) is to administer the NHGRI Genome Sequencing Program (GSP) in the areas of Mendelian disorders, pathogens and vectors of infectious diseases, comparative genome evolution, and medical sequencing. Prior to joining the NHGRI in 2006, she led the development and commercialization of a number of FDA 510(k)-cleared molecular products serving tissue/organ transplant diagnostics and immunogenetics research in general.
Dr. Wang serves on a number of NIH and external committees that coordinate or oversee rare disease gene discovery, organism-specific databases, or access to publically available genomic and phenotypic data. She is the author or coauthor of a number of research and review articles on transcriptional regulation, as well as on molecular diagnostic assay development.
Dr. Wang holds B.S. and M.S. degrees in genetics, and a Ph.D. in microbiology. She received her postdoctoral training at The Rockefeller University studying the transcriptional regulation of B-lymphocyte development.
Last Updated: November 26, 2012